telbivudine has been researched along with Disease Exacerbation in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li Wai Suen, CFD; Lokan, J; Mills, C; Sinclair, M; Sutherland, N | 1 |
| Chang, MY; Chen, YC; Hsu, CW; Yeh, CT | 1 |
| Ahn, SH; Hahn, KY; Han, KH; Kim, BK; Kim, DY; Kim, HC; Kim, JK; Kim, SU; Park, JY; Park, YH; Shin, SH | 1 |
| Deng, YR; Jin, QL; Lian, ZX; Matsuzaki, K; Moritoki, Y; Murata, M; Niu, JQ; Tsuneyama, K; Yamaguchi, T; Yoshida, K | 1 |
| Chang, KC; Chen, CH; Chiu, KW; Hu, TH; Hung, CH; Lee, CM; Lin, MT; Tsai, MC; Tseng, PL; Yen, YH; Yu, HC | 1 |
| Mallet, V; Pol, S; Vallet-Pichard, A | 1 |
| Abbott, WG; Dong, YH; Hou, JL; Huang, X; Jiang, XT; Li, YY; Liu, ZH; Ma, SW; Naoumov, NV; Sun, J; Sun, XF; Tang, LB; Zhang, YX | 1 |
1 review(s) available for telbivudine and Disease Exacerbation
| Article | Year |
|---|---|
The impact of human immunodeficiency virus on viral hepatitis.
Topics: Adenine; Antiviral Agents; Deoxycytidine; Disease Progression; Drug Therapy, Combination; Emtricitabine; Guanine; Hepatitis B; Hepatitis C; Hepatitis Viruses; HIV Infections; Humans; Interferon-alpha; Lamivudine; Nucleosides; Organophosphonates; Pyrimidinones; Telbivudine; Tenofovir; Thymidine | 2011 |
2 trial(s) available for telbivudine and Disease Exacerbation
| Article | Year |
|---|---|
Comparing the efficacy and clinical outcome of telbivudine and entecavir naïve patients with hepatitis B virus-related compensated cirrhosis.
Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; Disease Progression; DNA, Viral; Female; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Liver Cirrhosis; Male; Middle Aged; Proportional Hazards Models; Risk Factors; Telbivudine; Thymidine; Time Factors; Treatment Outcome | 2014 |
High serum IL-21 levels after 12 weeks of antiviral therapy predict HBeAg seroconversion in chronic hepatitis B.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Biomarkers; Disease Progression; DNA, Viral; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interleukins; Male; Nucleosides; Pyrimidinones; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Telbivudine; Thymidine; Treatment Outcome | 2012 |
4 other study(ies) available for telbivudine and Disease Exacerbation
| Article | Year |
|---|---|
Fibrosing Cholestatic Hepatitis-Like Syndrome in an Immunocompetent Patient With an Acute Flare of Chronic Hepatitis B.
Topics: Adenine; Biopsy, Needle; Cholestasis; Disease Progression; Follow-Up Studies; Hepatitis B, Chronic; Humans; Immunocompetence; Immunohistochemistry; Liver Cirrhosis; Liver Failure, Acute; Liver Function Tests; Male; Middle Aged; Organophosphonates; Severity of Illness Index; Syndrome; Telbivudine | 2019 |
On-treatment mortality predictors in chronic hepatitis B patients experiencing severe acute exacerbation: a prospective observational study.
Topics: Adult; Aged; alpha-Fetoproteins; Antiviral Agents; Bilirubin; Biomarkers; Disease Progression; Female; Glomerular Filtration Rate; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Prospective Studies; Prothrombin Time; Survival Analysis; Telbivudine; Thymidine; Treatment Outcome | 2013 |
Long-term outcomes of chronic hepatitis B virus infection in the era of antiviral therapy in Korea.
Topics: Adult; Age Factors; Antiviral Agents; Carcinoma, Hepatocellular; Disease Progression; Female; Follow-Up Studies; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Republic of Korea; Telbivudine; Thymidine; Time Factors; Treatment Outcome | 2014 |
Reversible phospho-Smad3 signalling between tumour suppression and fibrocarcinogenesis in chronic hepatitis B infection.
Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Disease Progression; DNA, Viral; Female; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Humans; Immunohistochemistry; Lamivudine; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Phosphorylation; Protein Isoforms; Signal Transduction; Smad3 Protein; Telbivudine; Thymidine; Treatment Outcome; Young Adult | 2014 |